Home | Site map | Elsevier websites | Alerts
Elsevier
Product information search
Search all Elsevier sites
Search
Advanced Product Search
Go to Elsevier home page
SiteStat.jsp
DOMESTIC ANIMAL ENDOCRINOLOGY

Guide for Authors

Domestic Animal Endocrinology publishes scientific papers dealing with the study of the endocrine physiology of domestic animal species. Those manuscripts utilizing other species as models for clinical or production problems associated with domestic animals will also be considered. Clinical Case Reports will generally not be accepted unless the research report provides significant new information regarding mechanisms responsible for a phenomenon. Topics covered include the regulation of hormone secretion, hormone action, and biochemical endocrinology.

Types of contribution
  1. Original Research Papers (Regular Papers)
  2. Review Articles
  3. Short Communications

Original Research Papers should report the results of original research. The material should not have been previously published elsewhere, except in a preliminary form.

Review Articles should cover subjects falling within the scope of the journal that are of active current interest. They may be submitted or invited.

Short Communications are concise but complete descriptions of a limited investigation, which will not be included in a later paper. Short Communications should be as completely documented, both by reference to the literature and description of experimental procedures employed, as an Original Research Paper. They should not occupy more than six printed pages (about 12 manuscript pages, including figures, tables and references).

Submission of manuscripts

Domestic Animal Endocrinology uses a system for the electronic handling of research papers during the submission and peer review process. Elsevier Editorial System (EES) is a web-based system with full online submission, review and status update capabilities, which allows you to upload files directly from your computer. All authors are required to submit their manuscripts electronically, at External link http://ees.elsevier.com/dae .

Circumstances relating to animal experimentation must meet the International Guiding Principles for Biomedical Research Involving Animals as issued by the Council for the International Organizations of Medical Sciences. These are obtainable from: Executive Secretary C.I.O.M.S., c/o WHO, Via Appia, CH-1211 Geneva 27, Switzerland or at the following URL: External link http://www.cioms.ch/frame_1985_texts_of_guidelines.htm .

Unnecessary cruelty in animal experimentation is not acceptable to the Editor of Domestic Animal Endocrinology.

Copyright
Submission of an article is understood to imply that the article is original and is not being considered for publication elsewhere. Submission also implies that all authors have approved the paper for release and are in agreement with its content, and that any person cited as a source of personal communications has approved such citation. It is understood that materials accepted for publication reflect the opinion(s) of the author(s) and should not be construed to represent the opinion of the Editor, the Editorial Board or the Publisher.

Upon acceptance of an article, Authors will be asked to transfer copyright (for more information on copyright see External link http://authors.elsevier.com ). This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding Author confirming receipt of the manuscript. A form facilitating transfer of copyright will be provided.

Authors' Rights
As an author you (or your employer or institution) may do the following:
  • make copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use
  • make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g., via an e-mail list or list server)
  • post a pre-print version of the article on Internet websites including electronic pre-print servers, and to retain indefinitely such version on such servers or sites
  • post a revised personal version of the final text of the article (to reflect changes made in the peer review and editing process) on your personal or institutional website or server, with a link to the journal homepage (on elsevier.com)
  • present the article at a meeting or conference and to distribute copies of the article to the delegates attending such a meeting
  • for your employer, if the article is a 'work for hire', made within the scope of your employment, your employer may use all or part of the information in the article for other intra-company use (e.g., training)
  • retain patent and trademark rights and rights to any processes or procedure described in the article
  • include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially)
  • use the article or any part thereof in a printed compilation of your works, such as collected writings or lecture notes (subsequent to publication of your article in the journal)
  • prepare other derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full acknowledgement of its original publication in the journal

NIH "Public Access" Policy
US National Institutes of Health (NIH) voluntary posting (" Public Access") policy Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access Policy"; see External link http://www.nih.gov/about/publicaccess/index.htm ) by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.

Preparation of manuscripts
Authors should have their manuscripts reviewed before submission by persons who have advanced command of English spelling, grammar, syntax and semantics and who are familiar with scientific style.

  1. Manuscripts should be written in clear, concise and grammatically correct English and formatted according to the instructions listed below. Authors whose native language is not English are strongly advised to have their manuscripts checked by an English speaking colleague prior to submission. Manuscripts that do not conform to standard English style, usage and grammar, and/or which are not adequately prepared, will be returned to the authors for modification prior to scientific review. Authors in Japan please note: Upon request, Elsevier Japan will provide authors with a list of people who can check and improve the English of their paper (before submission). Please contact our Tokyo office: Elsevier Japan, Editorial Service, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan; Tel.: 81 35561 5032; Fax: 81 35561-5045; E-mail: info@elsevier.co.jp
  2. Manuscripts should contain numbered lines and with wide margins and double-spacing throughout, i.e. also for abstracts, footnotes and references. Every page of the manuscript, including the title page, references, tables, etc. should be numbered. However, in the text no reference should be made to page numbers; if necessary, one may refer to sections. Avoid excessive usage of italics to emphasize part of the text.
  3. Manuscripts in general should be organized in the following order:

    Title, which should be clear, descriptive and not too long
    Running title, not more than 48 characters
    Name(s) of author(s)
    Complete postal address(es) of affiliation(s)
    Full telephone and fax numbers, and e-mail address, of the corresponding author
    Present address(es) of author(s) if applicable
    Complete correspondence address, including e-mail, to which proofs should be sent
    Abstract, not more than 250 words
    Five keywords (indexing terms)
    Introduction
    Materials and methods
    Results
    Discussion
    Acknowledgements and any additional information concerning research grants, etc.
    References
    Tables
    Figure captions


  4. In typing the manuscript, titles and subtitles should not be run within the text. They should be typed on a separate line, without indentation. Use lower-case letter type.
  5. SI units should be used.
  6. If a special instruction to the copy editor or typesetter is written on the copy it should be encircled. The typesetter will then know that the enclosed matter is not to be set in type. When a typewritten character may have more than one meaning (e.g. the lower case letter l may be confused with the numeral 1), a note should be inserted in a circle in the margin to make the meaning clear to the typesetter. If Greek letters or uncommon symbols are used in the manuscript, they should be written very clearly, and if necessary a note such as ''Greek lower-case chi'' should be put in the margin and encircled.
  7. Elsevier reserves the privilege of returning to the author for revision accepted manuscripts and illustrations that are not in the proper form given in this guide.

Assay validations For radioimmunoassays, it will be necessary to include a measure of precision relative to intra- and inter-assay variability. Antibodies and standards should be referenced.

Descriptions of new assays must include estimates of intra- and inter-assay variability, as well as statements relative to sensitivity, specificity, additivity, and parallelism.

Abstracts
The abstract should be clear, descriptive and not longer than 250 words.

Tables
  1. All tables should be referred to in the text by consecutive arabic numerals (Table 1, Table 2, etc.).
  2. Authors should take notice of the limitations set by the size and layout of the journal. Large tables should be avoided. Reversing columns and rows will often reduce the dimensions of a table.
  3. If many data are to be presented, an attempt should be made to divide them over two or more tables.
  4. Drawn tables, from which prints need to be made, should not be folded.
  5. Tables should be numbered according to their sequence in the text. The text should include references to all tables.
  6. Each table should be typewritten on a separate page of the manuscript. Tables should never be included in the text.
  7. Each table should have a brief and self-explanatory title.
  8. Column headings should be brief, but sufficiently explanatory. Standard abbreviations of units of measurement should be added between parentheses.
  9. Vertical lines should not be used to separate columns. Leave some extra space between the columns instead.
  10. Any explanation essential to the understanding of the table should be given as a footnote at the bottom of the table.

Illustrations
  1. All illustrations should be referred to in the text by consecutive arabic numerals (Figure 1, Figure 2, etc).
  2. Units should be indicated in the figures.
  3. Each illustration should be identified by its number and the name of the first author. An indication of the top of the illustrations is required in photographs of profiles, thin sections, and other cases where doubt can arise.
  4. Illustrations should be designed with the format of the page of the journal in mind. Illustrations should be of such a size as to allow a reduction of 50%.
  5. Make sure that the size of the lettering is big enough to allow a reduction of 50% without becoming illegible. The lettering should be in English. Use the same kind of lettering throughout and follow the style of the journal.
  6. If a scale should be given, use bar scales on all illustrations instead of numerical scales that must be changed with reduction.
  7. Each illustration should have a caption. The captions to all illustrations should be typed on a separate sheet of the manuscript.
  8. Explanations should be given in the typewritten legend. Drawn text in the illustrations should be kept to a minimum.
  9. Photographs are only acceptable if they have good contrast and intensity. Reproductions of photographs already printed cannot be accepted.
  10. If, together with your accepted article, you submit usable color figures, Elsevier will ensure that these figures appear free-of-charge in color in the electronic version of your paper, regardless of whether or not these illustrations are reproduced in color in the printed version. Color illustrations can only be included in print if the additional cost of reproduction is contributed by the author: you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please note that because of technical complications that may arise by converting color figures to 'grey scale' (for the printed version, should you not opt for color in print), you should submit in addition usable black and white prints corresponding to all the color illustrations.
  11. Advice on the preparation of illustrations can be found at the following URL: External link http://www.authors.elsevier.com/artwork

Preparation of supplementary data
Elsevier now accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect: External link http://www.sciencedirect.com . In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. Detailed instructions are available online on Elsevier's Author Gateway at the following URL: External link http://authors.elsevier.com/ArtworkInstructions.html?dc=AI43

References
  1. All publications cited in the text should be presented in a Reference section immediately following the Acknowledgements.
  2. References in the text should be indicated by Arabic numerals in parentheses and should be listed in the Reference section in numerical order.
  3. References should use the following style:
    a. For periodicals
    Connor EE, Ashwell MS, Dahl GE. Characterization and expression of the bovine growth hormone-releasing hormone (GHRH) receptor. Domest Anim Endocrinol 2002;22:189-200.
    b. For books
    Betteridge KJ. Embryo Transfer. In: Reproduction in Domesticated Animals, King GJ (Ed.), World Animal Science B9, Elsevier B.V., 1993, pp. 413-418.
    c. For multi-author books
    Van Zutphen LFM, Baumans V, Beynen AC. Principles of Laboratory Animal Science, Revised Edition. Elsevier B.V., 2001.
  4. Abbreviate the titles of periodicals mentioned in the list of references in accordance with BIOSIS Serial Sources, published annually by BIOSIS. The correct abbreviation for this journal is: Domest Anim Endocrinol.
  5. In the case of publications in any language other than English, the original title is to be retained. However, the titles of publications in non-Latin alphabets should be transliterated, and a notation such as "in Russian)" or "(in Greek, with English abstract)" should be added.
  6. Work accepted for publication but not yet published should be referred to as "in press."
  7. References concerning unpublished data and "personal communications" should not be cited in the reference list but may be mentioned in the text.

Formulae
  1. Formulae should be typewritten and not scanned, if possible. Leave ample space around the formulae.
  2. Subscripts and superscripts should be clear.
  3. Give the meaning of all symbols immediately after the equation in which they are first used.
  4. For simple fractions use the solidus (/) instead of a horizontal line, e.g. Ip/2m.
  5. Equations should be numbered serially at the right-hand side in parentheses. In general only equations explicitly referred to in the text need be numbered.
  6. The use of fractional powers instead of root signs is recommended. Powers of e are often more conveniently denoted by exp.
  7. In chemical formulae, valence of ions should be given as e.g., Ca2+, not as Ca++.
  8. Isotope numbers should precede the symbols, e.g. 18O.
  9. The repeated writing of chemical formulae in the text is to be avoided where reasonably possible; instead, the name of the compound should be given in full. Exceptions may be made in the case of a very long name occurring very frequently (e.g., phosphate as P2O5).

Footnotes
  1. Footnotes should only be used if absolutely essential. In most cases it should be possible to incorporate the information into the normal text.
  2. If used, they should be numbered in the text, indicated by superscript numbers, and kept as short as possible.

Nomenclature
  1. Authors and editors are, by general agreement, obliged to accept the rules governing biological nomenclature, as laid down in the International Code of Botanical Nomenclature, the International Code of Nomenclature of Bacteria, and the International Code of Zoological Nomenclature.
  2. All biotica (crops, plants, insects, birds, mammals, etc.) should be identified by their scientific names when the English term is first used, with the exception of common domestic animals.
  3. All biocides and other organic compounds must be identified by their Geneva names when first used in the text. Active ingredients of all formulations should be likewise identified.
  4. For chemical nomenclature, the conventions of the International Union of Pure and Applied Chemistry and the official recommendations of the IUPAC-IUB Combined Commission on Biochemical Nomenclature should be followed.

Permissions
  1. Authors, when quoting from someone else's work or when considering reproducing an illustration or table from a book or journal article, should make sure that they are not infringing a copyright.
  2. If excerpts from other copyrighted works are included, the Author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by Authors in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA: phone (+1) 215 239 3804, fax (+1) 215 239 3805, e-mail healthpermissions@elsevier.com. Requests may also be completed online via the Elsevier homepage (External link http://www.elsevier.com/locate/permissions ).
  3. Material in unpublished letters and manuscripts is also protected and must not be published unless permission has been obtained.
  4. A suitable acknowledgement of any borrowed material must always be made.

Proofs
One set of proofs will be sent by e-mail to the corresponding author as given on the title page of the manuscript. Only typesetter's errors may be corrected; no changes in, or additions to, the edited manuscript will be allowed.

Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.

Offprints
  1. An electronic offprint will be supplied free of charge.
  2. Additional paper offprints in multiples of 50 (up to a maximum of 400) can be ordered on an offprint order form, which is included with the proofs.
  3. UNESCO coupons are acceptable in payment of extra offprints.

Author Services
Enquiries concerning manuscripts and proofs: questions arising after acceptance of the manuscript, especially those relating to proofs, should be directed to Elsevier Ireland, Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland, tel.: +353 61 709600, fax: +353 61 709111/113.

Authors can also keep a track of the progress of their accepted article, and set up e-mail alerts informing them of changes to their manuscript's status, by using the "Track a Paper" feature of Elsevier's Author Gateway, External link http://authors.elsevier.com
Printer-friendly version   Printer-friendly version
 Home | Site map | Privacy policy | Terms and Conditions | Feedback | A Reed Elsevier company
 Copyright © 2007 Elsevier B.V. All rights reserved.